Forbes -
5 Oct 2014 13:14
Miscommunication and misinterpretation by DEA, states, and insurance companies of new rules to restrict prescriptions for hydrocodone combination products (mostly hydrocodone/acetaminophen) are leaving chronic pain patients confused and without their medicine.
Share this Article